BamSEC and AlphaSense Join Forces
Learn More

Acumen Pharmaceuticals Inc.

NASDAQ: ABOS    
Share price (8/14/25): $1.40    
Market cap (8/14/25): $84.8 million

Material Contracts Filter

EX-10.1
from 10-Q 61 pages Material contract
12/34/56
EX-10.1
from 10-Q 14 pages Employment Agreement
12/34/56
EX-10.11
from 10-K 7 pages Lease Agreement
12/34/56
EX-10.4
from 10-K 3 pages Acumen Pharmaceuticals, Inc. Non-Employee Director Compensation Policy Originally Adopted by the Board of Directors: Effective June 30, 2021 Amended by the Board of Directors: March 24, 2022 Amended by the Board of Directors: March 6, 2025
12/34/56
EX-10.15
from 10-K 50 pages Material contract
12/34/56
EX-10.14
from 10-K 48 pages Material contract
12/34/56
EX-10.13
from 10-K 44 pages Material contract
12/34/56
EX-10.1
from 10-Q 15 pages Material contract
12/34/56
EX-10.1
from 10-Q 15 pages Material contract
12/34/56
EX-10.12
from 10-K 6 pages Lease Agreement
12/34/56
EX-10.11
from 10-K 6 pages Lease Agreement
12/34/56
EX-10.1
from 10-K 25 pages Confidential Gs Sv Licence Row Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.10
from 10-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.9
from 10-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.8
from 10-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.7
from 10-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.3
from 10-K 2 pages Acumen Pharmaceuticals, Inc. Non-Employee Director Compensation Policy Originally Adopted by the Board of Directors: Effective June 30, 2021 Amended by the Board of Directors: March 24, 2022
12/34/56
EX-10.8
from 10-Q 11 pages Employment Agreement
12/34/56
EX-10.6
from S-1/A 15 pages Acumen Pharmaceuticals, Inc. Indemnification Agreement
12/34/56
EX-10.4
from S-1/A 12 pages Acumen Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan Adopted by the Board of Directors: June 22, 2021 Approved by the Stockholders: June 22, 2021
12/34/56